Sichuan Hebang Biotechnology (603077.SH): Glyphosate production line running at full capacity in the fourth quarter.

On January 3, Gelonghui reported that Sichuan Hebang Biotechnology (603077.SH) stated on the investor interaction platform that the company's Glyphosate production line is running at full capacity in the fourth quarter, and the financial situation related to gross margin should be based on the company's subsequent regular reports.

Gelonghui FinanceJan 3 15:54

Express News | Nearly 2,200 A-share companies have implemented share buybacks this year, with a total amount exceeding 160 billion yuan. Both Hangzhou Hikvision Digital Technology and WUXI APPTEC have buyback amounts surpassing 3 billion yuan.

BreakingsDec 31, 2024 20:05

The aggressively expanding Sichuan Hebang Biotechnology has encountered a crisis of market trust.

According to Investor Network, Sichuan Hebang Biotechnology Co., Ltd. (hereinafter referred to as "Hebang Biotechnology", 603077.SH) has enjoyed a stellar presence in the Capital Markets since its establishment in 2002, thanks to its strategic layout across various fields such as chemicals, Agriculture, and photovoltaics. However, in recent years, the company has faced multiple challenges including increasing financial pressure, ineffective strategic execution, and a crisis of market trust, making its future development uncertain, which has aroused widespread concern and doubt among investors. The financial predicament highlights the deteriorating financial situation of Hebang Biotechnology in recent years, especially with a decline in Net income. In 2023, the company's revenue

China InvestorsDec 21, 2024 08:01

Sichuan Hebang Biotechnology (603077.SH): First buyback of 1.5039 million shares.

On December 16, Gelonghui reported that Sichuan Hebang Biotechnology (603077.SH) announced the first repurchase under its current repurchase plan through centralized bidding on December 16, 2024, totaling 1,503,900 shares, accounting for 0.02% of the company's total equity. The highest price paid was 2.30 yuan/share, the lowest price was 2.29 yuan/share, and the total amount paid was 3,449,476.26 yuan.

Gelonghui FinanceDec 16, 2024 15:58

Sichuan Hebang Biotechnology (603077.SH): The second phase of employee stock ownership plan stock sale is completed.

Gelonghui, November 20th丨 Sichuan Hebang Biotechnology (603077.SH) announced that as of the date of this announcement, the stocks held by the second employee stock ownership plan have been completely sold through centralized bidding trading. This employee stock ownership plan has been implemented and terminated, and the company will carry out asset liquidation and distribution work in accordance with the relevant provisions of this employee stock ownership plan.

Gelonghui FinanceNov 20, 2024 16:07

sichuan hebang biotechnology (603077.SH): The company's project in Indonesia has recently started.

Grain Alliance November 15th, Sichuan Hebang Biotechnology (603077.SH) stated on the investor interaction platform that 1. The company's Indonesia project has recently started. 2. Since 2024, due to the impact of increased production capacity and declining downstream demand, the soda ash market prices have been continuously declining, with exceptionally intense market competition. As one of the only three soda ash production and sales companies in the southwestern region, the company has made a private equity investment in Chongqing Hanyou to integrate downstream customers and channels, optimize the soda ash business competitive environment, and help stabilize the soda ash market sales prices, avoiding unnecessary vicious competition, which is beneficial to both parties. 3. Your suggestion

Gelonghui FinanceNov 15, 2024 16:21